CUBE vs SRNE · P/E 25, rev $1.07B vs $385.9K cap
CubeSmart (CUBE) versus Sorrento Therape (SRNE) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Sorrento Therape (SRNE) is a biotechnology company listed on OTCQB.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
SRNE does not have a complete income-statement cache yet.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. SRNE currently screens at market cap $385.9K.
Not investment advice. Open the CUBE and SRNE stock pages for the full models.
Not investment advice.